Innovative Research in Cancer Nanotechnology (IRCN) (R01 Clinical Trial Not Allowed)

Organization
NIH
Type
NIH
Application or LOI Due Date
11-04-2020
Number
PAR-20-284
Comments
Application Due Dates: November 4, 2020, May 6, 2021, November 4, 2021, May 5, 2021, November 3, 3022, May 4, 2023
Brief Description

This Funding Opportunity Announcement (FOA) entitled "Innovative Research in Cancer Nanotechnology (IRCN)" encourages applications promoting transformative discoveries in cancer biology and/or oncology through the use of nanotechnology. Proposed projects should address major barriers in cancer biology and/or oncology using nanotechnology and should focus on mechanistic studies to expand the fundamental understanding of nanomaterial and/or nano-device interactions with biological systems. These studies are expected to be relevant to the delivery of nanoparticles and/or nano-devices to desired and intended cancer targets in vivo and/or characterization of detection and diagnostic devices and sensors in vitro. IRCN awards are expected to produce fundamental knowledge to aid future and more informed development of nanotechnology-based cancer interventions.